<
AI
Automation
Science
Innovation
Open Source
Blockchain
Social Media
Startups
Culture
Cloud
>

qz
Design Therapeutics, Inc. (DSGN) Is Up 6.92% in One Week: What You Should Know

Does Design Therapeutics, Inc. (DSGN) have what it takes to be a top stock pick for momentum investors? Let's find out. [...]

Discover Copy
Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

Destination
Engadget Podcast: iPhone 16e review and Amazon's AI-powered Alexa+

The keyword for the iPhone 16e seems to be "compromise." In this episode, Devindra chats with Cherlynn about her iPhone 16e review and try to figure out who this phone is actually for. Also, [...]

Match Score: 62.30

venturebeat
Anthropic ships major Claude Design overhaul with design system imports, code round-trips, and a fix for its token-burning problem

When Anthropic quietly released Claude Design in April as a "research preview," it generated the kind of instant traction most product teams dream about: more than one million users in its f [...]

Match Score: 59.32

thenextweb
Cambridge biotech STORM Therapeutics raises $56M

STC-15 is the world’s first RNA-modifying enzyme inhibitor to reach human trials. Phase 1 showed durable tumour regression across multiple sarcoma subtypes. The $56M Series C is backed entirely by e [...]

Match Score: 41.49

qz
After Plunging 30.8% in 4 Weeks, Here's Why the Trend Might Reverse for Maze Therapeutics, Inc. (MAZE)

The heavy selling pressure might have exhausted for Maze Therapeutics, Inc. (MAZE) as it is technically in oversold territory now. In addition to this technical [...]

Match Score: 38.61

qz
Strength Seen in Dianthus Therapeutics, Inc. (DNTH): Can Its 5.6% Jump Turn into More Strength?

Dianthus Therapeutics, Inc. (DNTH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions [...]

Match Score: 38.61

Destination
Viking Therapeutics closer to bringing its Ozempic competitor to market

Viking Therapeutics (VKTX), the developer of a promising experimental weight-loss drug, has announced a multi-year partnership with CordenPharma, a leading contract manufacturing firm.Read more... [...]

Match Score: 33.19

thenextweb
UCB pays up to $2.2bn for Candid Therapeutics, doubling down on T-cell engagers in autoimmune disease

The Belgian pharma is buying a two-year-old San Diego biotech for $2bn upfront, the second TCE bet it has placed in months. The thesis: B-cell killers built for cancer can rewire how autoimmune diseas [...]

Match Score: 33.19

venturebeat
Perceptron Mk1 shocks with highly performant video analysis AI model 80-90% cheaper than Anthropic, OpenAI & Google

AI that can see and understand what's happening in a video — especially a live feed — is understandably an attractive product to lots of enterprises and organizations. Beyond acting as a secu [...]

Match Score: 32.13

Destination
SAG-AFTRA has suspended its gaming industry strike over AI protections

SAG-AFTRA has suspended its strike against ten game studios. The organization's national board will meet tomorrow to consider a tentative agreement with the developers; more details of the arrang [...]

Match Score: 32.01